Clinical trials: Pyothorax

Pleural Empyema

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

• Completed
• Age: 6 months to 18 years
• Phase 3
• Results posted

Bacterial pneumonia can be complicated by the development of excess fluid and pus (pleural empyema) around the lungs in children. The incidence of pleural empyema in children has increased significantly in the last 10 years.

Trial name

NCT01717742

Testing

TPA (Tissue Plasminogen Activator), DNase

Where

6 sites in Canada

Volunteers

97 people

Sponsor

The Hospital for Sick Children